from Today's Healthcare News -- ScienceDaily http://ift.tt/1SDyAKA
Our mission is to advice, and to make the people of the world healthier through the power of information.
New agent developed for prostate cancer diagnosis, treatment
An agent called PSMA-617 is capable of attaching specifically to prostate cancer cells. This agent can be labeled with various radioactive substances. When chemically bound to a weakly radioactive diagnostic radionuclide, it can detect prostate tumors and their metastases in PET scans. If labeled with a strongly radioactive therapeutic radionuclide, PSMA-617 can specifically destroy cancer cells. A first clinical application of this radiopharmaceutica has now delivered promising results.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1SDyAKA
from Today's Healthcare News -- ScienceDaily http://ift.tt/1SDyAKA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment